{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:27:45Z","timestamp":1787923665484,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700603"],"award-info":[{"award-number":["2021YFC2700603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejogrb.2026.115168","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:43:30Z","timestamp":1777995810000},"page":"115168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pregnancy outcomes in non-thrombophilic women undergoing assisted reproductive technology receiving low molecular weight heparin"],"prefix":"10.1016","volume":"323","author":[{"given":"Dan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115168_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications","volume":"163","author":"Hao","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.ejogrb.2026.115168_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.fertnstert.2014.09.005","article-title":"Heparin for assisted reproduction: summary of a Cochrane review","volume":"103","author":"Akhtar","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2026.115168_b0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/14647270801995431","article-title":"Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial","volume":"11","author":"Qublan","year":"2008","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.ejogrb.2026.115168_b0020","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.fertnstert.2010.12.033","article-title":"The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study","volume":"95","author":"Berker","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2026.115168_b0025","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/dep086","article-title":"Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial","volume":"24","author":"Urman","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2026.115168_b0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.rbmo.2011.03.016","article-title":"Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study","volume":"22","author":"Noci","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2026.115168_b0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.thromres.2017.08.006","article-title":"The effect of parnaparin sodium on in vitro fertilization outcome: a prospective randomized controlled trial","volume":"159","author":"Lodigiani","year":"2017","journal-title":"Thromb Res"},{"issue":"17","key":"10.1016\/j.ejogrb.2026.115168_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12959-019-0213-9","article-title":"Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature","volume":"4","author":"Papadakis","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.ejogrb.2026.115168_b0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.fertnstert.2020.02.112","article-title":"Perinatal outcome in young patients with diminished ovarian reserve undergoing assisted reproductive technology","volume":"114","author":"Hu","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2026.115168_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13048-021-00863-4","article-title":"Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients","volume":"14","author":"Guo","year":"2021","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.ejogrb.2026.115168_b0055","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","article-title":"The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study","volume":"35","author":"Xu","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2026.115168_b0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.rbmo.2013.04.006","article-title":"Blastocyst culture and cryopreservation to optimize clinical outcomes of warming cycles","volume":"27","author":"Zhu","year":"2013","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115168_b0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/obr.12455","article-title":"Association between perinatal outcomes and maternal pre-pregnancy body mass index","volume":"17","author":"Liu","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.ejogrb.2026.115168_b0070","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1017\/S1368980020000828","article-title":"Comparison of different BMI cut-offs to screen for child and adolescent obesity in urban China","volume":"23","author":"Qian","year":"2020","journal-title":"Public Health Nutr"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115168_b0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejogrb.2026.115168_b0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humrep\/deu299","article-title":"Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group","volume":"30","author":"Kolte","year":"2015","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115168_b0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27928","article-title":"Associations of menstrual cycle characteristics across the reproductive life span and lifestyle factors with risk of type 2 diabetes","volume":"3","author":"Wang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejogrb.2026.115168_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103369","article-title":"Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment","volume":"148","author":"Sung","year":"2021","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0095","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/humupd\/dmt032","article-title":"Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis","volume":"19","author":"Potdar","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2026.115168_b0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.thromres.2014.06.004","article-title":"Low-molecular -weight heparin in pregnancies after ART -a retrospective study","volume":"134","author":"Grandone","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejogrb.2026.115168_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103674","article-title":"A retrospective study on IVF\/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment","volume":"153","author":"Zhang","year":"2022","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09513590.2017.1380182","article-title":"Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study","volume":"34","author":"Siristatidis","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/jrms.jrms_81_21","article-title":"The effect of low-molecular-weight heparin on live birth rate of patients with unexplained early recurrent pregnancy loss: a two-arm randomized clinical trial","volume":"27","author":"Mohammad-Akbari","year":"2022","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.ejogrb.2026.115168_b0120","first-page":"614","article-title":"Low-molecularweight heparin in women with repeated implantation failure","volume":"31","author":"Xiong","year":"2015","journal-title":"J Pract Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00795-019-00220-x","article-title":"Heparin prevents oxidative stress-induced apoptosis in human decidualized endometrial stromal cells","volume":"52","author":"Tamaru","year":"2019","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI0214996","article-title":"Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins","volume":"110","author":"Wang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2026.115168_b0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humupd\/dmn031","article-title":"The potential role of heparin in assisted conception","volume":"14","author":"Nelson","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2026.115168_b0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108259","article-title":"Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss","volume":"208","author":"Wang","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejogrb.2026.115168_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1008923","article-title":"Uterine cytokine profiles after low-molecular-weight heparin administration are associated with pregnancy outcomes of patients with repeated implantation failure","volume":"13","author":"Niu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejogrb.2026.115168_b0155","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers."},{"issue":"7970","key":"10.1016\/j.ejogrb.2026.115168_b0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-023-06298-9","article-title":"A spatially resolved timeline of the human maternal-fetal interface","volume":"619","author":"Greenbaum","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115168_b0165","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/CM9.0000000000003114","article-title":"Role of maternal-fetal immune tolerance in the establishment and maintenance of pregnancy","volume":"137","author":"Wang","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115168_b0170","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.thromres.2009.11.030","article-title":"Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy","volume":"125","author":"Oberkersch","year":"2010","journal-title":"Thromb Res"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526002368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526002368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:45:59Z","timestamp":1787921159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526002368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"alternative-id":["S0301211526002368"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115168","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes in non-thrombophilic women undergoing assisted reproductive technology receiving low molecular weight heparin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115168"}}